By contrast, MAO-B inhibitors are suitable for the treatment of the neurodegenerative diseases Alzheimer’s disease and Parkinson’s disease [5,7,8,11,12]. The gene discussed is MAOB; the disease is early-onset autosomal dominant Alzheimer disease.